PARP1 and diabetes mellitus: The mice were extremely resistant to streptozotocin and the β-cell death was prevented.8–11) PARP deficient mice were resistant against not only single-high-dose streptozotocin-induced diabetes, as described above, but also multiple-low-dose streptozotocin-induced diabetes.62)